Cannabis Study Shows THC Can Slow Primary Marker of Alzheimer’s Disease


“While we are certainly not advocating the use of illegal drugs, these findings offer convincing evidence that THC possesses remarkable inhibitory qualities, especially when compared to AChE inhibitors currently available to patients.”
—Kim Janda

Here’s a quick glance at what you’ll find in their study:

“Scientists at The Scripps Research Institute have found that the active ingredient in marijuana, tetrahydrocannabinol or THC, inhibits the formation of amyloid plaque, the primary pathological marker for Alzheimer’s disease. In fact, the study said, THC is “a considerably superior inhibitor of [amyloid plaque] aggregation” to several currently approved drugs for treating the disease.

The study was published online August 9 in the journal Molecular Pharmaceutics, a publication of the American Chemical Society.”

Full Article:
A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology

Scripps Summary of the Article:
Marijuana’s Active Ingredient Shown to Inhibit Primary Marker of Alzheimer’s Disease

Share This Post

1 Comment

Leave a Reply